Matrix Laboratories Limited is pleased to announce the appointment of William A. Haseltine, Ph.D, an eminent scientist, as the Chairman of Matrix Scientific Advisory Board (MSAB). He is the founder of Human Genome Sciences Inc., the pioneer genomics biotechnology company. He was the chairman and Chief Executive Officer of Human Genome Sciences from 1993 to 2004. He is a Professor at The Scripps Research Institute.

Dr. Haseltine has a distinguished record of academic achievement in both cancer and AIDS research, for which he has received numerous awards and honors. He is the author of more than 250 published scientific manuscripts.

Dr. Haseltine holds a doctorate from Harvard University in Biophysics and was a professor at Harvard Medical School and Harvard School of Public Health from 1976 to 1993. In addition to his scientific work, Dr. Haseltine has been active in business for more than 20 years. He is the founder of seven biotechnology companies and, as an advisor to HealthCare Ventures, helped to create another 20 companies.

Dr. Haseltine is active in Scientific and Medical Organizations. He is a member of the Board of Directors of One World health, The Alliance for ageing Research, and the National Health Museum. He is Co-chair at the Presidents Council of Cold Spring Harbor Laboratories and serves on the CEO Council of the New York Academy of Sciences.

Dr Haseltine is also involved in Public and International Policy. He is a member of the Board of Directors of the U.S chamber of Commerce, the Executive Committee of The Brookings Institution, The American Academy in Berlin and The Chairman's circle of the Asia Society. He is a member of the The Trilateral Commission and The Council on Foreign Relations.

The scope of the Scientific Advisory Board include advising the company on emerging areas in pharmaceutical industry, in-licensing and out-licensing opportunities, alliances in emerging areas, techno-legal issues and assisting the company in identification of therapeutic areas for New Drug Discovery.

"Dr. Haseltine's appointment as the Chairman of Matrix Scientific Advisory Board (MSAB) adds great value and depth to the company. We hope to carry out exciting scientific work under the guidance of Dr. Haseltine", said Mr. N Prasad, the Chairman and CEO of Matrix.

"I am delighted to be associated with Matrix Labs. I believe that the Indian pharmaceutical industry, Matrix Labs in particular, has the opportunity to be a central player in the emergence of a new rational, efficient and global pharmaceutical and biotechnology industry. I look forward to work with the outstanding team of Matrix Labs", Dr. Haseltine said on his appointment.